ScholarWorks@Gachon: Baek, Han Joo

Detailed Information

Baek, Han Joo (백한주)

College of Medicine (Department of Medicine)

Research Area: 의학

Tel 032-460-8426
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Rheumatoid arthritis:6||Treatment:5||Ankylosing spondylitis:5||Behcet syndrome:4||Gout:4||Axial spondyloarthritis:4||Behcet&apos:4||Rheumatic diseases:4||Arthritis:4||Recommendations:4||rheumatoid:3||rheumatoid arthritis:3||Celecoxib:3||.:2||Coronavirus:2||Crosscultural adaptation:2||Expert consensus:2||HLAB27:2||Inflammatory arthritis:2||Inflammatory back pain:2||Medical profession:2||Medical professionalism:2||Methotrexate:2||NSAIDs:2||Prognosis:2||SARSCoV2:2||Spondyloarthritis:2||Tocilizumab:2||ankylosing spondylitis:2||s Disease Current Activity Form:2||s disease:2||Diseasemodifying antirheumatic drugs:1||Enophthalmos:1||Enterocolic lymphocytic phlebitis:1||Etanercept:1||Etoricoxib:1||척추관절염:1||Flares:1||Gender identity:1||Gene Polymorphism:1||Glucocorticoids:1||Axial:1||Gout Onset:1||Gout flare:1||s or American College of Rheumatology criteria:1||HLAB51 antigen:1||Health Care:1||Humidity:1||Hypertension:1||Iloprost:1||Immunosuppression:1||Infectious myositis:1||sacroiliitis:1||serum uric acid:1||Knee osteoarthritis:1||Korea:1||Korean:1||Korean patients:1||LBEC0101:1||Localized gastrointestinal vasculitis:1||Low back pain:1||Magnetic resonance imaging:1||Matrix metalloproteinase 3:1||spondyloarthritis:1||survival:1||syndrome:1||Multiple:1||Mycobacterium tuberculosis:1||systemic lupus erythematosus:1||Noninferiority:1||Osteoarthritis:1||Outcome:1||Outcome measures:1||PG201:1||Pain control:1||Particulate matter:1||Pelubiprofen:1||Polymyalgia Rheumatica:1||Polymyositis:1||Positron emission tomography:1||tacrolimus:1||Prophylactic duration:1||Pulmonary:1||Pulmonary arterial hypertension:1||Pulmonary hypertension:1||Quality Indicators:1||Quality of Health Care:1||Questionnaires:1||Radiation dosage:1||Randomized controlled trial:1||Autoimmune Inflammatory Rheumatic Diseases:1||Reliability:1||Reliability and validity:1||Remission:1||Republic of Korea:1||Artefacts:1||Rheumatoid:1||Alcohol:1||Risk factor:1||tocilizumab:1||Season:1||Seasonality:1||Selfreport measure:1||Sensorineural hearing loss:1||Severity of illness index:1||Singleorgan vasculitis:1||South Korea:1||Spine:1||Spondylitis:1||treatment:1||Steroids:1||Summer:1||Switch:1||Symptoms:1||Systemic lupus erythematosus:1||Systolic pulmonary artery pressure:1||T Cells:1||Temperature:1||Tin:1||uterine leiomyoma:1||Tomography:1||Air pollution:1||Treatment response:1||Tuberculous destroyed lung:1||Urate lowering treatment:1||Vaccines:1||Vasculitis:1||Visual analogue pain scale:1||Xray computed:1||ankylosing:1||강직성 척추염:1||ascites:1||axial spondyloarthritis:1||bDMARDs:1||body mass index:1||bone mineral density:1||cardiovascular diseases:1||clinician&apos:1||comorbidity:1||concomitant rheumatic disease:1||corticosteroids:1||disease activity:1||disease progression:1||fibromyalgia:1||flare:1||functional classification:1||gout treatment:1||herpes zoster:1||infection:1||interleukin33:1||interleukin6:1||mean platelet volume:1||methotrexate:1||molecular targeted therapy:1||neoplasms:1||noninferiority:1||osteoporosis:1||postinflammation:1||prophylactic duration:1||pseudoMeigs&apos:1||rheumatic diseases:1||Age of onset:1||Acupuncture:1||Behcet's disease:1||Biological diseasemodifying antirheumatic drugs:1||Biomarker:1||Biosimilar:1||CNS lymphoma:1||COVID19:1||COX2 inhibitor:1||Behçet’s Disease Current Activity Form:1||Chronic obstructive pulmonary disease:1||Combination therapy:1||Connective tissue diseases:1||Cor pulmonale:1||risk factor:1||염증성 등통증:1||Delayed diagnosis:1||Dermatomyositis:1||Disease Management:1||

STATISTICS: Total View :3,702,106; Today View :94

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE